Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Metabolism. 2017 Oct 3;78:155–166. doi: 10.1016/j.metabol.2017.09.014

Figure 2. Correlations of ApoJ levels and risk factors for insulin resistance in nondiabetic (ND) and type 2 diabetic (T2D) subjects.

Figure 2

Relationship of serum ApoJ with (a) fasting insulin levels, (b) fasting glucose levels, (c) HOMA-IR, (d) HOMA-β (%), (e) BMI, and (f) age.

HHS Vulnerability Disclosure